Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $170.63 | 7 | 40.5% |
| Travel and Lodging | $161.20 | 1 | 38.3% |
| Education | $89.00 | 1 | 21.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Adaptive Biotechnologies Corporation | $331.83 | 8 | $0 (2024) |
| Incyte Corporation | $89.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $331.83 | 8 | Adaptive Biotechnologies Corporation ($331.83) |
| 2023 | $89.00 | 1 | Incyte Corporation ($89.00) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $22.20 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Travel and Lodging | Cash or cash equivalent | $161.20 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $1.45 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $0.82 | General |
| Category: ONCOLOGY | ||||||
| 04/07/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $64.98 | General |
| Category: ONCOLOGY | ||||||
| 04/07/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $31.62 | General |
| Category: ONCOLOGY | ||||||
| 04/07/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $26.35 | General |
| Category: ONCOLOGY | ||||||
| 04/07/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $23.21 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2023 | Incyte Corporation | — | Education | Cash or cash equivalent | $89.00 | General |
About Dr. Snegha Ananth, MBBS
Dr. Snegha Ananth, MBBS is a Hematology & Oncology healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2017. The National Provider Identifier (NPI) number assigned to this provider is 1629508817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Snegha Ananth, MBBS has received a total of $420.83 in payments from pharmaceutical and medical device companies, with $331.83 received in 2024. These payments were reported across 9 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($170.63).
Practice Information
- Specialty Hematology & Oncology
- Location Omaha, NE
- Active Since 06/19/2017
- Last Updated 10/10/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1629508817
Products in Payments
- clonoSEQ (Device) $331.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Omaha
James Armitage, Md, MD
Hematology & Oncology — Payments: $1.5M
Margaret Block, M.d, M.D
Hematology & Oncology — Payments: $444,214
Julie Vose, Md, MD
Hematology & Oncology — Payments: $194,187
Peter Silberstein, M.d, M.D
Hematology & Oncology — Payments: $143,878
Apar Kishor Ganti, Md, MD
Hematology & Oncology — Payments: $135,871
Dr. Krishna Gundabolu, M.d, M.D
Hematology & Oncology — Payments: $75,519